CompletedPhase 2

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

NCT00096720

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Pacific Neuroscience Medical Group

Oxnard, California, United States

+12 additional locations

Save this trial

Pacific Neuroscience Medical GroupOxnard, California, United States
Colorado Neurology, PCEnglewood, Colorado, United States
Institute for Neurodegenerative DisordersNew Haven, Connecticut, United States
University of Florida Movement Disorders CenterGainesville, Florida, United States
Northwestern UniversityChicago, Illinois, United States
RUSH University Medical CenterChicago, Illinois, United States
Boston University Medical CenterBoston, Massachusetts, United States
Lahey Clinic Medical CenterBurlington, Massachusetts, United States
Parkinson's Disease and Movement Disorders Center of Albany Medical CollegeAlbany, New York, United States
Duke UniversityDurham, North Carolina, United States
University of PennsylvaniaPhiladelphia, Pennsylvania, United States
NeuroHealth, Inc.Warwick, Rhode Island, United States
University of Tennessee Health Science CenterMemphis, Tennessee, United States